alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         138,650
<SECURITIES>                                         0
<RECEIVABLES>                                   27,479
<ALLOWANCES>                                       935
<INVENTORY>                                      6,960
<CURRENT-ASSETS>                               177,272
<PP&E>                                          21,955
<DEPRECIATION>                                  11,787
<TOTAL-ASSETS>                                 187,775
<CURRENT-LIABILITIES>                           34,087
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            46
<OTHER-SE>                                     153,642
<TOTAL-LIABILITY-AND-EQUITY>                   187,775
<SALES>                                         69,789
<TOTAL-REVENUES>                                69,789
<CGS>                                           17,391
<TOTAL-COSTS>                                   28,626
<OTHER-EXPENSES>                                    21
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 27,636
<INCOME-TAX>                                     9,396
<INCOME-CONTINUING>                             18,240
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    18,240
<EPS-BASIC>                                       0.40
<EPS-DILUTED>                                     0.39


</TABLE>
# C_2014395EN.01004502.xml

| 10.11.2014 | EN | Official Journal of the European Union | C 395/45 |
| --- | --- | --- | --- |

10.11.2014

EN

Official Journal of the European Union

C 395/45

---

Judgment of the General Court of 26 September 2014 — Brainlab v OHIM (Curve)

(Case T-266/13) (1)

((Community trade mark - Application for Community word mark Curve - Absolute ground for refusal - Trade mark contrary to public policy or to accepted principles of morality - Article 7(1)(f) of Regulation (EC) No 207/2009))

(2014/C 395/56)

Language of the case: German

Parties

Applicant: Brainlab AB (Feldkirchen, Germany) (represented by: J. Bauer, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: G. Schneider, acting as Agent)

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 15 March 2013 (Case R 2073/2012-4), concerning an application for registration of the word mark Curve as a Community trade mark.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders Brainlab AG to pay the costs. |
| --- | --- |

2.

Orders Brainlab AG to pay the costs.

---

(1)  OJ C 215, 27.7.2013.

---
IN THE SUPREME COURT OF THE STATE OF DELAWARE

COREY GREEN

- HALL, Defendant Below, Appellant,

v. GENISYS CREDIT UNION , Plaintiff Below, Appellee. § § No. 2 22 , 202 4 § § Court Below

– Superior Court § of the State of Delaware § § C.A. No. N24C

- 04

- 032 § § § § ORDER The appellant, Corey Green

- Hall, filed this appeal from the Superior Court’s
order directing that a writ of replevin issue. On July 9, 2024, the Court denied Green

Hall’s motion to proceed in forma pauperis

. The Senior Court Clerk advised Green

Hall to pay the filing fee by July 23, 2024 , or a notice to show cause would issue.
Hall

- Green failed to pay the filing fee. On July 24, 2024, the Chief Deputy Clerk issued a notice, by certified mail, directing Hall

- Green to show cause why this appeal should not be dismissed for his failure to pay the filing fee. Because the return receipt filed with the Cou rt was unsigned, the Chief Deputy Clerk reissued the notice, again by certified mail. Postal records show that the notice has been out for delivery and awaiting delivery since August 23, 2024. On September 9, 2024, the Chief Deputy Clerk reissued the not ice to show cause by first

- class mail. All three notices were sent to the address that Hall

- Green provided to this Court. To date,2

Hall

- Green has not paid the filing fee, responded to the notice to show cause , or reported any change of address to the Court . Dismissal of the appeal is therefore deemed to be unopposed. NOW, THEREFORE, IT IS ORDERED, under Supreme Court Rules 3(b)(2) and 29(b), that the appeal be DISMISSED.

BY THE COURT: /s/ Gary F. Traynor Justice
COURT OF APPEALS OF VIRGINIA

Present: Chief Judge Felton, Judge Elder and Senior Judge Annunziata

COLLEEN D. HARLOW MEMORANDUM OPINION * v. Record No. 2386-10-2 PER CURIAM APRIL 5, 2011 CAPITAL ONE SERVICES AND ROYAL INDEMNITY COMPANY

FROM THE VIRGINIA WORKERS’ COMPENSATION COMMISSION (Jean M. McKeen; Tomlin & McKeen, PLLC, on brief), for appellant. (Claire C. Carr; Rachel A. Rior dan; Kalbaugh Pfund & Messersmith, on brief), for appellees.

Colleen D. Harlow (claimant) appeals a decision of the Workers’ Compensation Commission. On appeal, she contends the commi ssion erred in (1) failing to award claimant a lower extremity permanent impairment rating; (2) finding claimant had no permanent impairment rating for her lower extremity after the commission previously determined claimant suffered some type of impairment rating for her lower left extremity; and (3) relying on Dr. Steven Fiore’s medical opinion because Dr. Fi ore’s opinion failed to consider claimant’s sensory and neurological deficits. We have reviewed the record a nd the commission’s opinion and find that this appeal is without merit. A ccordingly, we affirm for the reasons stated by the commission in its final opinion. See Harlow v. Capital One Servs. , VWC File No. 217-37-61 (Oct. 13, 2010). We dispense with oral argumen t and summarily affirm because the facts and

* Pursuant to Code § 17.1-413, this opin ion is not designated for publication.- 2 - legal contentions are adequately presented in th e materials before the Court and argument would not aid the decisional process. See Code § 17.1-403; Rule 5A:27.

Affirmed.
No. 10-6241.

#### Patricia T. Patterson, Petitioner v. Daniel Shearous.

562 U.S. 1013, 131 S. Ct. 528,

178 L. Ed. 2d 389,

2010 U.S. LEXIS 8575.

November 1, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 382 Fed. Appx. 290.
##### 



EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002 I, Philip A. Garcia, certify that:  1.
    
    I have reviewed this annual report on Form 10-K/A of Erie Family
Life Insurance Company for the year ended December 31, 2003;2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this report;4.
    
    The registrants other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
registrant and have:  a.
    
    Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report
is being prepared;b.
    
    Evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by
this report based on such evaluation; andc.
    
    Disclosed in this report any change in the
registrants internal control over financial reporting that
occurred during the registrants most recent fiscal quarter
that has materially affected, or is reasonably likely to
materially affect, the registrants internal control over
financial reporting; and  5.
    
    The registrants other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over
financial reporting, to the registrants auditors and the audit
committee of registrants board of directors:  a.
    
    All significant deficiencies and material weaknesses
in the design or operation of internal control over financial
reporting, which are reasonably likely to adversely affect the
registrants ability to record, process, summarize and report
financial information; andb.
    
    Any fraud, whether or not material, that involves
management or other employees who have a significant role in
the registrants internal control over financial reporting. Date: August 20, 2004 /s/ Philip A. GarciaPhilip A. Garcia, Executive Vice President & CFO
 64
i i i i i i

MEMORANDUM OPINION

No. 04-09-00019-CR

Felipe Aguilar VILLANUEVA,

Appellant

v.

The STATE of Texas,

Appellee

From the 175th Judicial District Court, Bexar County, Texas

Trial Court No. 2005-CR-8864

Honorable Mary Roman, Judge Presiding

PER CURIAM

Sitting: Catherine Stone, Chief Justice

Steven C. Hilbig, Justice

Marialyn Barnard, Justice

Delivered and Filed: February 18, 2009

DISMISSED FOR LACK OF JURISDICTION

The trial court imposed sentence on September 22, 2008, and appellant filed a timely motion

for new trial. The deadline for filing a notice of appeal was therefore December 22, 2008. See TEX.

R. APP. P. 26.2(a)(1). A notice of appeal was not filed until December 24, 2008. The certificate of

service on the notice of appeal to the Bexar County District Attorney’s Office is dated December 19,

2009. However, it does not indicate whether the notice of appeal was filed with the clerk’s office

by mail and the record does not contain a copy of an envelope bearing a postmark. See Villareal v.
04-09-00019-CR

-2-

State, 199 S.W.3d 30 (Tex. App.—San Antonio 2006, order), disp. on merits, No. 04-06-00022-CR,

2007 WL 120625 (Tex. App.—San Antonio Jan. 19, 2007, pet. ref’d) (holding inmate’s notice of

appeal was timely filed when delivered in properly-addressed envelope to jail authorities on or before

due date and received by clerk within ten days of filing deadline); TEX.R.APP. P. 9.2. Appellant did

not file a timely motion for extension of time to file the notice of appeal. See TEX. R. APP. P. 26.3.

Because the notice of appeal in this case appeared to be untimely, we issued a show cause

order on January 16, 2009, ordering appellant to file a response establishing that the notice of appeal

was timely filed by mail, or showing cause why the appeal should not be dismissed for want of

jurisdiction. See Olivo v. State, 918 S.W.2d 519, 522 (Tex. Crim. App. 1996) (holding timely notice

of appeal is necessary to invoke court of appeal’s jurisdiction). In response, appellant’s appointed

counsel filed a letter stating that after reviewing the record and speaking with the trial court’s clerks,

he is “unable to show cause why this appeal should not be dismissed for want of jurisdiction.” 

Accordingly, because appellant has failed to establish the notice of appeal was timely filed,

we lack jurisdiction to entertain the appeal. See id.; see also Ater v. Eighth Court of Appeals,

802 S.W.2d 241 (Tex. Crim. App. 1991) (explaining that writ of habeas corpus pursuant to article

11.07 of the Texas Code of Criminal Procedure governs out-of-time appeals from felony

convictions).

Accordingly, we dismiss this appeal for want of jurisdiction.

PER CURIAM

Do not publish
非活动性结核(TB)检测和治 疗

想一想 我是否有感染结核病的风险?

如果您有以下情况,请与您的医疗保健提供者讨论进行检测:

最近有与患有活动性结

核病的人呆在一起

出生在或经常前往

结核病常见的国家,

包括亚洲、非洲和拉

丁美洲的国家

由于某些药物或健康状况

(如糖尿病、癌症和艾滋

生活在或曾经生活在结核病 病),免疫系统较弱

比较常见的大群体环境中,如

无家可归者收容所、监狱或牢

房

在结核病传播风险高的地方工作,如医

院、无家可归者收容所、教养所和疗养

院

即使是接种过结核病疫苗(也称为卡介苗)的人,也应该进行检

测,因为疫苗会随着时间的推移而减弱。

我需要做什么结

核病检测?

结核病感染检测有两种类型: 结核血

检和结核皮试。对于接种过结核病疫

苗(卡介苗)的人来说,结核血检是

首选的 

结核病检测方法。

医疗保健提供者和患者应讨论哪种检

测是最好的。

我有哪些治疗选择?

要了解更多关于结核病以及如何保护自己和他人的信息,请访问 

www.cdc.gov/thinktesttreattb

301110

在美国,多达 1300 万人可能患有非活动性结核病

(也称为潜伏性结核感染)。如果不进行治疗,每 10 个非活动性结核病患

者中就有 1 个会患上活动性结核病,并可通过空气将结核病传播给其他人。

您可以帮助防止结核病的传播。

检测 治疗

治疗非活动性结核病是保护 

您不发展成活动性结核病的最好方法。在

可能的情况下,CDC建议对非活动性结核病

使用短期和方便的3或4个月的利福霉素治

疗。
#### Com. v. Pierre

04/20/2016

770 MAL (2015)

Denied

Pa.Super., 133 A.3d 81
No. 10-6464.

#### Benjamin Rodriguez-Aponte, Petitioner v. United States.

562 U.S. 989, 131 S. Ct. 432,

178 L. Ed. 2d 336,

2010 U.S. LEXIS 8206.

October 18, 2010.

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
[Federal Register Volume 63, Number 124 (Monday, June 29, 1998)]
[Notices]
[Page 35243]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17173]



[[Page 35243]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.

    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclosed confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Cancer Institute Initial Review 
Group Subcommittee C--Basic & Preclinical.
    Date: July 28-30, 1998.
    Time: 7:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, N.W., 
Washington, DC 20007.
    Contact Person: Virginia P. Wray, Phd, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6130 Executive Boulevard--
Room 635, Rockville, MD 20895-7405, 301/496-9236.

(Catalogue of Federal Domestic Assistance Program Nos. 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control; 93.392, Cancer 
Construction, National Institutes of Health, HHS)

    Dated: June 23, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-17173 Filed 6-26-98; 8:45 am]
BILLING CODE 4140-01-M
[4910-13-PI

v ONCUR"l:NCTiS 

# "~'TIIGISzrL INITI,\IS1SIG 

### tV. flld~M D.'TF, 

# 5'-"Ho RO\m,'Q W"80L 

# ." 

## - 7 !¥..(. "ITIAU'SLG 

### C. 

### C,love..- DATE 

## 3'-1;;(-10 "OU,I~G''-''iWL 

## - J 

# 14 Federal Aviation Administration DEPARTMENT OF TRANSPORTATION

Airworthiness Directives; Bombardier, Inc. Model BD-l 00-1AI

# a (Challenger 300) RlN 2120-AA64 [Docket No. FAA-2009-1214j Directorate Identifier 2009-NM-091-ADj Amendmen 

## IQ61 0010-07-010 39-*****; AD H**_**_**) 14 CFR Part 39
Airplanes AGENCY: Federal Aviation Administration (FAA), Department ofTransportation (DOT). 

## 3-j1-J~ ROuriNG ',"MHol 

## -)01 ACTION: Final rule.
condition on an aviation product. The MeAl describes the unsafe condition as: above. This AD results from mandatory continuing airworthiness information (MeAl) originated by an aviation authority of another country to identify and correct an unsafe SUMMARY: We are adopting anew airworthiness directive (AD) for the products liste "OUnNG~"'~ 

### 0 y-o 

### -100 

# 7f];Aptn-7; oMLi 

# 3 ;C jei There has been an incident during aproduction flight test where the proximity-sensor electronic unit (PSEU) failed. This resulted in unannunciated loss of: INIT1AL,i"G

·\Vheel brakes below 10 knots;
· Thrust reverser;
·Nose wheel steering; and
·Auto-deployment ofthe multi-fill1ction spoilers. A similar condition, ifnot corrected, may result inreduced controllability ofthe aircraft upon landing and possible overrun ofthe nmway. 

# , * 

# , , , 

# , ,
# S1 6rv- - T-Q ~. ~.~- a~/-~j ~ 

# (~ ~- 

# Y KdX 

# -SChbelMkP - G (- c ~

- ~ -- - L.P.C.LY?G ~.~ W ~t~Y~ C ~ ~~f~~ ~ - - -

ce 2- ; 2 c - ~ L6, 

## Cjb\

~ 3 

## 1\)Ai

- HA Nh? C A - 7 7g 23 0 -58'
- 2- tL 

### 5 s- ~

a-o 

### ~h~6~~1~ 1~~az ~-- 

## - ~~9~ ~~c~~ ? -- ~~t~l.~~

it.. l ~ , f~ r_i l ~ b - - - -



### I 

### 0 2

A ~ 72,5

- m~ b-V 

## A. C) , r~ . - 2- 

### 2-1q (v ~ 

## _5_6,q o

C 

### a rr i
#### People v Morehouse

3d Dept: 140 AD3d 1202 (Warren)

denied 8/8/16 (Fahey, J.)
EXHIBIT 99.1


CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF SARBANES-OXLEY
ACT OF 2002


In connection with the quarterly report on Form 10-QSB of PCS Research
Technology, Inc. (the " Company") for the quarterly period ended September 30,
2002 (the " Report"), the undersigned hereby certifies in his capacity as Chief
Executive Officer of the Company, pursuant to 18 U.S.C. Section 1350 as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge and belief:

         1.  The Report fully complies with the requirements of Section 13 (a)
             or 15(d) of the Securities Exchange Act of 1934, as amended; and

         2.  The information contained in the Report fairly presents, in all
             material respects, the financial condition and results of
             operations of the Company.


Dated: November 13, 2002               By: /s/ BRIAN M. OVERSTREET
                                           -------------------------------------
                                           Name:  Brian M. Overstreet
                                           Title: Chief Executive Officer


In connection with the quarterly report on Form 10-QSB of DirectPlacement, Inc.
(the " Company") for the quarterly period ended September 30, 2002 (the "
Report"), the undersigned hereby certifies in his capacity as Chief Financial
Officer of the Company, pursuant to 18 U.S.C. Section 1350 as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my
knowledge and belief:

         1.  The Report fully complies with the requirements of Section 13 (a)
             or 15(d) of the Securities Exchange Act of 1934, as amended; and

         2.  The information contained in the Report fairly presents, in all
             material respects, the financial condition and results of
             operations of the Company.



Dated: November 13, 2002               By: /s/ MICHAEL H. LORBER
                                           -------------------------------------
                                           Name:  Michael H. Lorber
                                           Title: Chief Financial Officer


                                       26
No. 10-7176.

#### Nolan C. Davis, Sr., Petitioner v. Marlin N. Gusman, Sheriff, Orleans Parish Prison, et al.

562 U.S. 1147, 131 S. Ct. 923,

178 L. Ed. 2d 769,

2011 U.S. LEXIS 53.

January 10, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
[Federal Register Volume 63, Number 124 (Monday, June 29, 1998)]
[Notices]
[Pages 35243-35244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17177]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Board of Scientific Counselors, National Cancer Institute.

    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), 
Title 5 U.S.C., as amended for the review, discussion, and 
evaluation of individual intramural programs and projects conducted 
by the National Cancer Institute, including consideration of 
personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.
    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute Subcommittee B--Basic Sciences.
    Date: July 6, 1998.
    Open: 8:30 am to 8:50 am.
    Agenda: Call to Order by Board Chair and presentation by NCI 
Director regarding the Bypass Budget 2001.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892 301/
496-2378.
    Closed: 8:50 am to Adjournment.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Florence E. Farber, Phd, Executive Secretary, 
Office of Advisory Activities, Division of Extramural Activities, 
National Cancer Institute, National Institutes of Health 6130 
Executive Boulevard, EPN 609, Rockville, MD 20892 301/496-2378.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer

[[Page 35244]]

Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 
93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 
93.398 Cancer Research Manpower; 93.399, Cancer Control; 93.392, 
Cancer Construction, National Institute of Health, HHS)

    Dated: June 23, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-17177 Filed 6-26-98; 8:45 am]
BILLING CODE 4140-01-M